Carlyle Group Amends QuidelOrtho Stake Filing
Ticker: QDEL · Form: SC 13D/A · Filed: Jun 25, 2024 · CIK: 1906324
| Field | Detail |
|---|---|
| Company | Quidelortho Corp (QDEL) |
| Form Type | SC 13D/A |
| Filed Date | Jun 25, 2024 |
| Risk Level | medium |
| Pages | 9 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.001, $39.80, $39.99, $39.9154, $40.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: ownership-change, sec-filing, schedule-13d
TL;DR
Carlyle just updated their 13D on QuidelOrtho - check for changes in ownership.
AI Summary
Carlyle Group Inc. filed an amendment to its Schedule 13D on June 25, 2024, regarding its beneficial ownership of QuidelOrtho Corp. The filing indicates a change in the reporting person's holdings, though specific new dollar amounts or share counts are not detailed in this excerpt. The amendment pertains to the ownership of QuidelOrtho Corp, a company specializing in in vitro and in vivo diagnostic substances.
Why It Matters
This filing signals a potential shift in a major shareholder's position in QuidelOrtho, which could influence the company's stock performance and strategic direction.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings can indicate strategic shifts by major investors, potentially impacting stock price and company strategy.
Key Players & Entities
- Carlyle Group Inc. (company) — Filing entity
- QuidelOrtho Corp (company) — Subject company
- 20240625 (date) — Filing date
FAQ
What specific changes in beneficial ownership are reported by Carlyle Group Inc. for QuidelOrtho Corp?
The filing is an amendment to a Schedule 13D, indicating a change in reporting person's holdings, but the specific details of the change (e.g., number of shares, percentage ownership) are not provided in this excerpt.
When was this amendment to the Schedule 13D filed?
The amendment was filed on June 25, 2024.
What is the primary business of QuidelOrtho Corp?
QuidelOrtho Corp is involved in In Vitro & In Vivo Diagnostic Substances, with SIC code 2835.
Who is the filing entity and what is their primary business?
The filing entity is Carlyle Group Inc., primarily engaged in Investment Advice, with SIC code 6282.
What is the Central Index Key (CIK) for QuidelOrtho Corp?
The CIK for QuidelOrtho Corp is 0001906324.
Filing Stats: 2,599 words · 10 min read · ~9 pages · Grade level 6.8 · Accepted 2024-06-25 17:00:08
Key Financial Figures
- $0.001 — relating to the common stock, par value $0.001 per share (the “Common Stock&rdqu
- $39.80 — rice Per Share June 12, 2024 18,344 $39.80 to $39.99 $39.9154 June 12, 2024 44
- $39.99 — hare June 12, 2024 18,344 $39.80 to $39.99 $39.9154 June 12, 2024 44,950 $40.
- $39.9154 — une 12, 2024 18,344 $39.80 to $39.99 $39.9154 June 12, 2024 44,950 $40.00 to $40.
- $40.00 — 9.99 $39.9154 June 12, 2024 44,950 $40.00 to $40.9991 $40.3379 June 12, 2024
- $40.9991 — 9154 June 12, 2024 44,950 $40.00 to $40.9991 $40.3379 June 12, 2024 969 $41.00
- $40.3379 — e 12, 2024 44,950 $40.00 to $40.9991 $40.3379 June 12, 2024 969 $41.00 to $41.18
- $41.00 — 40.9991 $40.3379 June 12, 2024 969 $41.00 to $41.18 $41.1490 June 13, 2024 11
- $41.18 — 40.3379 June 12, 2024 969 $41.00 to $41.18 $41.1490 June 13, 2024 11,956 $36.
- $41.1490 — June 12, 2024 969 $41.00 to $41.18 $41.1490 June 13, 2024 11,956 $36.70 to $36.
- $36.70 — 1.18 $41.1490 June 13, 2024 11,956 $36.70 to $36.9995 $36.8927 June 13, 2024
- $36.9995 — 1490 June 13, 2024 11,956 $36.70 to $36.9995 $36.8927 June 13, 2024 99,264 $37.
- $36.8927 — e 13, 2024 11,956 $36.70 to $36.9995 $36.8927 June 13, 2024 99,264 $37.00 to $37.
- $37.00 — 9995 $36.8927 June 13, 2024 99,264 $37.00 to $37.9999 $37.5186 June 13, 2024
- $37.9999 — 8927 June 13, 2024 99,264 $37.00 to $37.9999 $37.5186 June 13, 2024 26,314 $38.
Filing Documents
- formsc13da.htm (SC 13D/A) — 271KB
- 0001493152-24-025117.txt ( ) — 273KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : June 25, 2024 The Carlyle Group Inc. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II GP L.L.C. By: The Carlyle Group Inc., its sole member By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Chief Financial Officer Carlyle Holdings II L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director CG Subsidiary Holdings L.L.C. By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings, L.P. By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group Cayman Investment Holdings Sub L.P. By: TC Group Cayman Investment Holdings, L.P., its general partner By: CG Subsidiary Holdings L.L.C., its general partner By: /s/ Anne Frederick, attorney-in-fact Name: John C. Redett Title: Managing Director TC Group VI Cayman, L.L.C. By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President TC Group VI Cayman, L.P. By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President Carlyle Partners VI Cayman Holdings, L.P. By: TC Group VI Cayman, L.P., its general partner By: TC Group VI Cayman, L.L.C., its general partner By: /s/ Jeremy W. Anderson Name: Jeremy W. Anderson Title: Vice President